Philadelphia CCFA Hosts Crohn’s and Colitis Education Day
Philadelphia CCFA Hosts Crohn’s and Colitis Education Day Philadelphia CCFA Hosts Crohn’s & Colitis Patient Education Day at Thomas … PR Web (press release) This free program provides a supportive environment for patients, families and caregivers to learn about Crohn’s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD). Currently, Crohn’s disease and [...]
War Inside Our Bodies Living with Inflammatory Disease
War Inside Our Bodies Living with Inflammatory Disease Our bodies rely on a complex immune system to keep us healthy, but for those with inflammatory disease it can feel as if their immune system has turned against them. With International Day of Immunology coming up on 29 April, Rebecca Scott talks to researchers working to [...]
Work Out What Matters Most Your Mind
Work Out What Matters Most Your Mind Only 20 minutes so far? I can’t keep sitting on this bike. It hurts. I’ll just leave class and use the restroom. I don’t need to go to the bathroom, but it will give my rear end a break. What if everyone stares at me? Oh no, now [...]
Ulcerative Colitis Weekend Surgery Adds Complication Risk
Weekend hospitalization for ulcerative colitis is associated with an increased risk for postoperative complications, according to the findings of a large retrospective study. The weekend effect is the well-described phenomenon of worse outcomes for patients hospitalised on a weekend compared with a weekday,” the authors write. However, this effect may not exist across all healthcare [...]
Ulcerative Colitis Clinical Trial Immune Initiates Bertilimumab Phase II
Ulcerative Colitis Clinical Trial Immune Initiates Bertilimumab Phase II Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that Immune is initiating, following authorization from Israeli health authorities, a Phase II double-blind placebo controlled study with its lead drug, bertilimumab, in patients with [...]
FDA approves Delzicol to treat ulcerative colitis
FDA has approved Delzicol as a treatment for ulcerative colitis, according to a press release. Delzicol (mesalamine, Warner Chilcott) is intended to treat mild-to-moderate ulcerative colitis (UC) and maintenance of remission. The drug will be available in 400-mg, delayed-release capsules, with an approved dosage of 800 mg three times a day for treatment and a [...]
Ulcerative Colitis associated Cytomegalovirus Infection
A trigger role of cytomegalovirus (CMV) was shown in the development of ulcerative colitis (UC) in mice. Fifteen cases of synchronous onset of CMV colitis and UC have been reported in literature. A careful prospective and retrospective survey identified CMV colitis in newly diagnosed UC patients at 4.5% (3/65 cases) and 8.2% (5/61 cases), respectively. [...]
Niacin Lovastatin
Niacin Lovastatin (trade names Advicor, Mevacor) is a drug combination used for the treatment of dyslipidemia. It is a combination of the vitamin niacin and the statin drug lovastatin. The combination preparation is marketed by Abbott Laboratories It was approved by the FDA on December 17, 2001. Dosage The combination is available as tablets containing:. [...]
Triamcinolone
Triamcinolone is a long-acting synthetic corticosteroid given orally, by injection, by inhalation, or as a topical ointment or cream. Triamcinolone is used to treat several different medical conditions, such as eczema, psoriasis, arthritis, allergies, ulcerative colitis, lupus, sympathetic ophthalmia, temporal arteritis, uveitis, ocular inflammation, Urushiol-induced contact dermatitis visualization during vitrectomy and the prevention of asthma [...]
Humira FDA approves Ulcerative Colitis
MedPage TodayHumira: Rheumatoid Arthritis Drug Approved By FDA To Treat Ulcerative ColitisHuffington PostIn addition to rheumatoid arthritis, the medicine is approved for psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasi…
Free Commission Review: